Stephen Hanauer to Recombinant Fusion Proteins
This is a "connection" page, showing publications Stephen Hanauer has written about Recombinant Fusion Proteins.
Connection Strength
0.064
-
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997 Oct 09; 337(15):1029-35.
Score: 0.034
-
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells. Exp Hematol. 1996 Jun; 24(7):823-8.
Score: 0.031